Increased level of beta-amyloid in the brain of bulbectomized mice

Biochemistry (Mosc). 2004 Feb;69(2):176-80. doi: 10.1023/b:biry.0000018948.04559.ab.

Abstract

Six weeks after bilateral olfactory bulbectomy, a peptide with molecular weight of 4 kD was revealed in extracts of the neocortex and hippocampus from mice. Using monoclonal antibodies 4G8, this peptide was identified as beta-amyloid. Its level was significantly higher in the bulbectomized animals than in sham-operated mice. The bulbectomized mice displayed sharp impairment in spatial memory when tested in the Morris water maze. The results suggest that bulbectomy initiates in the brain a pathological process similar to human Alzheimer's disease in location, biochemistry, and behavioral manifestations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / etiology
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / physiopathology
  • Amyloid beta-Peptides / analysis
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Behavior, Animal / physiology
  • Brain Chemistry*
  • Disease Models, Animal
  • Hippocampus / chemistry
  • Hippocampus / metabolism*
  • Humans
  • Male
  • Maze Learning / physiology
  • Memory / physiology
  • Mice
  • Neocortex / chemistry
  • Neocortex / metabolism*
  • Olfactory Pathways / surgery
  • Peptide Fragments / analysis
  • Peptide Fragments / metabolism

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments